Provexis PLC operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Provexis PLC with three other pharmaceutical manufacturers in Europe: Moberg Pharma AB (publ) of SWEDEN (2020 sales of 50.49 million Swedish Kronor [US$6.05 million] ), Oncimmune Holdings PLC (£509,000.00 [US$693,461.60 ] of which 100% was Distribution of testing products), and Medincell SA which is based in FRANCE (2.85 million Euros [US$3.46 million] of which 100% was mers allowing the controlled and prolong).

Sales Analysis. During the year ended March of 2020, sales at Provexis PLC were £347,937.00 (US$474.03 thousand). This is an increase of 8.0% versus 2019, when the company's sales were £322,189.00 . This was the fifth consecutive year of sales increases at Provexis PLC (and since 2015, sales have increased a total of 810%).